Egesta Lopci (E Lopci)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 46

Top Topics

Systematic Review

Squamous Cell Carcinoma

Positron Emission Tomography

Top Venues

Diagnostics (Basel, Switzerland)

European journal of nuclear medicine and molecular imaging

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Akram N Al-Ibraheem, Ahmed Saad Abdlkadir, Egesta Lopci, Sudqi Allouzi, Diana Paez, Maryam Alkuwari, Mohammad Ma'koseh, Fuad Novruzov, Sharjeel Usmani, Kamal Al-Rabi, Asem H Mansour
FDG-PET in Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy Toxicity: A Systematic Review. Cancers 16 (9) (2024)
Akram N Al-Ibraheem, Ahmed Saad Abdlkadir, Egesta Lopci, Sudqi Allouzi, Diana Paez, Maryam Alkuwari, Mohammad Ma'koseh, Fuad Novruzov, Sharjeel Usmani, Kamal Al-Rabi, Asem H Mansour
FDG-PET in Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy Toxicity: A Systematic Review. Cancers 16 (9) (2024)
María Mangas Losada, Leonardo Romero Robles, Alejandro Mendoza Melero, Irene García Megías, Amós Villanueva Torres, Puy Garrastachu Zumarán, Xavier Boulvard Chollet, Egesta Lopci, Rafael Ramírez Lasanta, Roberto C Delgado Bolton
[ 18 F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy. Diagnostics (Basel, Switzerland) 13 (5) (2023)
Conor M Prendergast, Kathleen M Capaccione, Egesta Lopci, Jeeban P Das, Alexander N Shoushtari, Randy Yeh, Daniel Amin, Laurent Dercle, Dorine de Jong
More than Just Skin-Deep: A Review of Imaging's Role in Guiding CAR T-Cell Therapy for Advanced Melanoma. Diagnostics (Basel, Switzerland) 13 (5) (2023)
María Mangas Losada, Leonardo Romero Robles, Alejandro Mendoza Melero, Irene García Megías, Amós Villanueva Torres, Puy Garrastachu Zumarán, Xavier Boulvard Chollet, Egesta Lopci, Rafael Ramírez Lasanta, Roberto C Delgado Bolton
[ 18 F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy. Diagnostics (Basel, Switzerland) 13 (5) (2023)
Matteo Caracciolo, Angelo Castello, Luca Urso, Francesca Borgia, Maria Cristina Marzola, Licia Uccelli, Corrado Cittanti, Mirco Bartolomei, Massimo Castellani, Egesta Lopci
Comparison of MRI vs. [ 18 F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives. Journal of clinical medicine 12 (16) (2023)
Conor M Prendergast, Egesta Lopci, Romain-David Seban, Dorine de Jong, Samy Ammari, Sanjay Aneja, Antonin Levy, Abin Sajan, Mary M Salvatore, Kathleen M Cappacione, Lawrence H Schwartz, Eric Deutsch, Laurent Dercle
Integrating [ 18 F]-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography with Radiation Therapy and Immunomodulation in Precision Therapy for Solid Tumors. Cancers 15 (21) (2023)
Elisabetta Maria Abenavoli, Flavia Linguanti, Raffaella Calabretta, Roberto C Delgado Bolton, Valentina Berti, Egesta Lopci
Clinical Application of ImmunoPET Targeting Checkpoint Inhibitors. Cancers 15 (23) (2023)
Valli De Re, Egesta Lopci, Giulia Brisotto, Caterina Elia, Lara Mussolin, Maurizio Mascarin, Emanuele Stefano Giovanni d'Amore, null Aieop The Hodgkin's Lymphoma Research Network
Preliminary Study of the Relationship between Osteopontin and Relapsed Hodgkin's Lymphoma. Biomedicines 12 (1) (2023)
Conor M Prendergast, Kathleen M Capaccione, Egesta Lopci, Jeeban P Das, Alexander N Shoushtari, Randy Yeh, Daniel Amin, Laurent Dercle, Dorine de Jong
More than Just Skin-Deep: A Review of Imaging's Role in Guiding CAR T-Cell Therapy for Advanced Melanoma. Diagnostics (Basel, Switzerland) 13 (5) (2023)
Akram N Al-Ibraheem, Ahmed Saad Abdlkadir, Qaid Ahmed Shagera, Omar Saraireh, Dhuha Al-Adhami, Rakan Al-Rashdan, Farah Anwar, Serin Moghrabi, Issa Mohamad, Kristoff Muylle, Enrique Estrada, Diana Paez, Asem Mansour, Egesta Lopci
The Diagnostic and Predictive Value of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Laryngeal Squamous Cell Carcinoma. Cancers 15 (22) (2023)
Flavia Linguanti, Elisabetta Maria Abenavoli, Raffaella Calabretta, Valentina Berti, Egesta Lopci
ImmunoPET Targeting Receptor Tyrosine Kinase: Clinical Applications. Cancers 15 (24) (2023)
Flavia Linguanti, Elisabetta Maria Abenavoli, Raffaella Calabretta, Valentina Berti, Egesta Lopci
ImmunoPET Targeting Receptor Tyrosine Kinase: Clinical Applications. Cancers 15 (24) (2023)
Hayley Higgins, Abanoub Nakhla, Andrew Lotfalla, David Khalil, Parth Doshi, Vandan Thakkar, Dorsa Shirini, Maria Bebawy, Samy Ammari, Egesta Lopci, Lawrence H Schwartz, Michael Postow, Laurent Dercle
Recent Advances in the Field of Artificial Intelligence for Precision Medicine in Patients with a Diagnosis of Metastatic Cutaneous Melanoma. Diagnostics (Basel, Switzerland) 13 (22) (2023)
Luca Urso, Elena Bonatto, Alberto Nieri, Angelo Castello, Anna Margherita Maffione, Maria Cristina Marzola, Corrado Cittanti, Mirco Bartolomei, Stefano Panareo, Luigi Mansi, Egesta Lopci, Luigia Florimonte, Massimo Castellani
The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review. Cancers 15 (7) (2023)
Valli De Re, Egesta Lopci, Giulia Brisotto, Caterina Elia, Lara Mussolin, Maurizio Mascarin, Emanuele Stefano Giovanni d'Amore, null Aieop The Hodgkin's Lymphoma Research Network
Preliminary Study of the Relationship between Osteopontin and Relapsed Hodgkin's Lymphoma. Biomedicines 12 (1) (2023)
Jeremy McGale, Jakob Hama, Randy Yeh, Laetitia Vercellino, Roger Sun, Egesta Lopci, Samy Ammari, Laurent Dercle
Artificial Intelligence and Radiomics: Clinical Applications for Patients with Advanced Melanoma Treated with Immunotherapy. Diagnostics (Basel, Switzerland) 13 (19) (2023)
Egesta Lopci, N Aide, A Dimitrakopoulou-Strauss, L Dercle, A Iravani, R D Seban, C Sachpekidis, O Humbert, O Gheysens, A W J M Glaudemans, W A Weber, A D Van den Abbeele, R L Wahl, A M Scott, N Pandit-Taskar, R J Hicks
Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [ 18 F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors. Cancer imaging : the official publication of the International Cancer Imaging Society 22 (1) (2022)
Egesta Lopci
Meditating on Cancer Management at the Time of Immunotherapy. Journal of clinical medicine 11 (11) (2022)
Egesta Lopci, N Aide, A Dimitrakopoulou-Strauss, L Dercle, A Iravani, R D Seban, C Sachpekidis, O Humbert, O Gheysens, A W J M Glaudemans, W A Weber, A D Van den Abbeele, R L Wahl, A M Scott, N Pandit-Taskar, R J Hicks
Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [ 18 F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors. Cancer imaging : the official publication of the International Cancer Imaging Society 22 (1) (2022)
Flavia Linguanti, Elisabetta Maria Abenavoli, Valentina Berti, Egesta Lopci
Metabolic Imaging in B-Cell Lymphomas during CAR-T Cell Therapy. Cancers 14 (19) (2022)
Laurent Dercle, Shawn H Sun, Romain-David Seban, Ahmed Mekki, Roger Sun, Lambros Tselikas, Sophie Hans, Alice Bernard-Tessier, Fadila Mihoubi Bouvier, Nicolas Aide, Laetitia Vercellino, Alexia Rivas, Antoine Girard, Fatima-Zohra Mokrane, Guillaume Manson, Roch Houot, Egesta Lopci, Randy Yeh, Samy Ammari, Lawrence H Schwartz
Emerging and Evolving Concepts in Cancer Immunotherapy Imaging. Radiology (2022)
Egesta Lopci, N Aide, A Dimitrakopoulou-Strauss, L Dercle, A Iravani, R D Seban, C Sachpekidis, O Humbert, O Gheysens, A W J M Glaudemans, W A Weber, A D Van den Abbeele, R L Wahl, A M Scott, N Pandit-Taskar, R J Hicks
Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [ 18 F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors. Cancer imaging : the official publication of the International Cancer Imaging Society 22 (1) (2022)
Egesta Lopci, N Aide, A Dimitrakopoulou-Strauss, L Dercle, A Iravani, R D Seban, C Sachpekidis, O Humbert, O Gheysens, A W J M Glaudemans, W A Weber, A D Van den Abbeele, R L Wahl, A M Scott, N Pandit-Taskar, R J Hicks
Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [ 18 F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors. Cancer imaging : the official publication of the International Cancer Imaging Society 22 (1) (2022)
Matteo Caracciolo, Angelo Castello, Luca Urso, Francesca Borgia, Naima Ortolan, Licia Uccelli, Corrado Cittanti, Massimo Castellani, Mirco Bartolomei, Massimo Lazzeri, Egesta Lopci
The Role of [ 68 Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review. Cancers 14 (20) (2022)
Angelo Castello, Massimo Castellani, Luigia Florimonte, Luca Urso, Luigi Mansi, Egesta Lopci
The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria. Journal of clinical medicine 11 (6) (2022)
Egesta Lopci, R J Hicks, A Dimitrakopoulou-Strauss, L Dercle, A Iravani, R D Seban, C Sachpekidis, O Humbert, O Gheysens, A W J M Glaudemans, W Weber, R L Wahl, A M Scott, N Pandit-Taskar, N Aide
Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [ 18 F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0. European journal of nuclear medicine and molecular imaging 49 (7) (2022)
Egesta Lopci
Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [18F]FDG PET/CT in Metastatic Melanomas and Lung Cancer. Journal of clinical medicine 10 (21) (2021)
Egesta Lopci, Piergiuseppe Colombo, Massimo Lazzeri
Mismatched Imaging Findings of Prostate Cancer Diagnosis: 68 Ga-PSMA PET/CT vs mpMRI. Nuclear medicine and molecular imaging 55 (4) (2021)
Egesta Lopci, Silvia Morbelli
Advances in Lung Cancer Imaging and Therapy. Cancers 14 (1) (2021)
Angelo Castello, Sabrina Rossi, Luca Toschi, Egesta Lopci
Impact of Antibiotic Therapy and Metabolic Parameters in Non-Small Cell Lung Cancer Patients Receiving Checkpoint Inhibitors. Journal of clinical medicine 10 (6) (2021)
Matteo Bauckneht, Carlo Genova, Giovanni Rossi, Erika Rijavec, Maria Giovanna Dal Bello, Giulia Ferrarazzo, Marco Tagliamento, Maria Isabella Donegani, Federica Biello, Silvia Chiola, Lodovica Zullo, Stefano Raffa, Francesco Lanfranchi, Giuseppe Cittadini, Cecilia Marini, Egesta Lopci, Gianmario Sambuceti, Francesco Grossi, Silvia Morbelli
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab. Cancers 13 (13) (2021)
Egesta Lopci, Roberta Burnelli, Caterina Elia, Arnoldo Piccardo, Angelo Castello, Eugenio Borsatti, Pietro Zucchetta, Angelina Cistaro, Maurizio Mascarin, null null
Additional value of volumetric and texture analysis on FDG PET assessment in paediatric Hodgkin lymphoma: an Italian multicentric study protocol. BMJ open 11 (3) (2021)
Egesta Lopci, Angelo Castello, Emanuela Mazziotti
Multimodality imaging of ectopic focus in Graves' Disease. Nuclear medicine review. Central & Eastern Europe 23 (1) (2021)
Angelo Castello, Lorenza Rimassa, Nicola Personeni, Tiziana Pressiani, Valeria Smiroldo, Egesta Lopci
Metabolic Switch in Hepatocellular Carcinoma Patients Treated with Sorafenib: a Proof-of-Concept Trial. Molecular imaging and biology 22 (5) (2021)
Angelo Castello, Carlo Russo, Fabio Grizzi, Dorina Qehajaj, Egesta Lopci
Prognostic Impact of Intratumoral Heterogeneity Based on Fractal Geometry Analysis in Operated NSCLC Patients. Molecular imaging and biology 21 (5) (2020)
Angelo Castello, Sabrina Rossi, Luca Toschi, Luigi Mansi, Egesta Lopci
Soluble PD-L1 in NSCLC Patients Treated with Checkpoint Inhibitors and Its Correlation with Metabolic Parameters. Cancers 12 (6) (2020)
Egesta Lopci, G Lughezzani, A Castello, P Colombo, P Casale, A Saita, N M Buffi, G Guazzoni, A Chiti, M Lazzeri
PSMA-PET and micro-ultrasound potential in the diagnostic pathway of prostate cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (1) (2020)
Angelo Castello, Luca Toschi, Sabrina Rossi, Emanuela Mazziotti, Egesta Lopci
The immune-metabolic-prognostic index and clinical outcomes in patients with non-small cell lung carcinoma under checkpoint inhibitors. Journal of cancer research and clinical oncology 146 (5) (2020)
Angelo Castello, Francesco Giuseppe Carbone, Sabrina Rossi, Simona Monterisi, Davide Federico, Luca Toschi, Egesta Lopci
Circulating Tumor Cells and Metabolic Parameters in NSCLC Patients Treated with Checkpoint Inhibitors. Cancers 12 (2) (2020)
Fabio Grizzi, Angelo Castello, Dorina Qehajaj, Luca Toschi, Sabrina Rossi, Daniela Pistillo, Valentina Paleari, Giulia Veronesi, Pierluigi Novellis, Simona Monterisi, Rossana Mineri, Daoud Rahal, Egesta Lopci
Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer. Cancer immunology, immunotherapy : CII 68 (9) (2019)
Egesta Lopci, Maurizio Mascarin, Arnoldo Piccardo, Angelo Castello, Caterina Elia, Luca Guerra, Eugenio Borsatti, Alessandra Sala, Alessandra Todesco, Pietro Zucchetta, Piero Farruggia, Angelina Cistaro, Salvatore Buffardi, Patrizia Bertolini, Maurizio Bianchi, Maria Luisa Moleti, Feisal Bunkheila, Paolo Indolfi, Franca Fagioli, Alberto Garaventa, Roberta Burnelli, null null
FDG PET in response evaluation of bulky masses in paediatric Hodgkin's lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial. European journal of nuclear medicine and molecular imaging 46 (1) (2018)
Fabio Grizzi, Angelo Castello, Egesta Lopci
Is it time to change our vision of tumor metabolism prior to immunotherapy? European journal of nuclear medicine and molecular imaging 45 (6) (2018)
Egesta Lopci, Michel Meignan
Deauville score: the Phoenix rising from ashes. European journal of nuclear medicine and molecular imaging 46 (5) (2018)
Egesta Lopci, Marco Riva, Laura Olivari, Fabio Raneri, Riccardo Soffietti, Arnoldo Piccardo, Alberto Bizzi, Pierina Navarria, Anna Maria Ascolese, Roberta Rudà, Bethania Fernandes, Federico Pessina, Marco Grimaldi, Matteo Simonelli, Marco Rossi, Tommaso Alfieri, Paolo Andrea Zucali, Marta Scorsetti, Lorenzo Bello, Arturo Chiti
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma. European journal of nuclear medicine and molecular imaging 44 (7) (2017)
Sabrina Rossi, Luca Toschi, Angelo Castello, Fabio Grizzi, Luigi Mansi, Egesta Lopci
Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors. European journal of nuclear medicine and molecular imaging 44 (13) (2017)